Cancer cells have not necessarily lost all the genes that control proliferation and differentiation. Thus, in many cancers at least some of the tumour cells exhibit abortive attempts at normal differentiation, sometimes proceeding to terminally differentiated post-mitotic cells, as was shown for myeloid leukaemias, squamous cell carcinomas, teratocarcinomas, neuroblastomas and rhabdomyosarcomas (Pierce, 1974a,b; Dexter et al., 1977; Strickland & Mahdavi, 1978; Linder et al., 1981; Moore et al., 1986; Paukovits et al., 1986; Sidell et al., 1986; Sachs, 1987; Gabbert et al., 1988) . These observations stimulated attempts to induce differentiation as an alternative to standard cytotoxic chemotherapy (for review see Freshney, 1985) .
Sarcomas have received less attention, partly because cell type specific markers of differentiation are not easily available in many established sarcoma cell lines. We now report the establishment of a new model for differentiation induction in sarcomas, using the clonal rhabdomyosarcoma cell line BA-HAN-IC, which was derived from a dimethylbenzanthracene-induced rhabdomyosarcoma in rat . This clonal rhabdomyosarcoma cell line BA-HAN-IC closely imitates embryonic rhabdomyogenesis and is composed of myogenically committed but morphologically undifferentiated mononuclear stem cells, some of which fuse to form multinuclear myotube-like giant cells with morphological features of rhabdomyogenic differentiation, such as bundles of thick and thin myofilaments. Furthermore, the mitotic activity in our rhabdomyosarcoma cell line is entirely confined to the mononuclear cell compartment, whereas the myotube-like giant cells have irreversibly withdrawn from the mitotic cycle and represent terminally differentiated postmitotic cells . In this report, we show that fetal calf serum and retinoic acid are able to affect the proliferation and differentiation of our clonal rhabdomyosarcoma cell line BA-HAN-IC, and that the control mechanisms of proliferation and differentiation known from embryonic myogenesis are not completely lost in this cell line.
Material and methods

Cells and culture
The clonal cell line BA-HAN-Cl was derived from a dimethylbenzanthracene-induced rhabdomyosarcoma in rat Received 3 June 1988; and in revised form, 22 September 1988. (1989), 59, 61-67 the tumour cells were fixed in situ and further handled as described previously flasks per concentration. As a control, the frequency of myotube-like giant cells was determined in five culture flasks each with standard growth medium or standard growth medium with 0.02% ethanol, respectively. At the end of the observation period of 96 hours, the total number of tumour cells was determined in each culture flask. Because the formation of myotube-like giant cells by fusion is affected by cell density, the effects of different culture conditions on cell proliferation and cell density had to be compensated. To this end, the relative frequency of myotube-like giant cells, i.e. the ratio between the number of myotube-like giant cells and the total number of cells per culture flask, was calculated.
Creatine kinase activity Triplicate samples of 5 x 106 cells grown for ten days in growth medium with 1% FCS or growth medium with 1 M retinoic acid, respectively, were disrupted by sonication. After centrifugation, the total creatine kinase activity, which was used as a biochemical differentiation marker (Delaporte et al., 1986; Garvin et al., 1986) , was determined at 37°C on an Olympus AU 5031 analyser using the CK-test (NAC-activated) from Merck (Darmstadt, FRG).
Assessment of growth properties in vitro Growth rate Fifteen replicate 25 cm2 culture flasks were each exposed to differentiation-inducing medium. As a control, 15 replicate 25 cm2 flasks were each exposed to standard growth medium and standard growth medium supplemented with 0.02% ethanol, respectively. Each culture flask was seeded with 5 x 104 cells. In each experiment, cells from three culture flasks were harvested separately each day for five days and haemocytometer cell counts with the Neubauer chamber were performed. Cells were not refed during this period.
Plating efficiency Tumour cells were seeded onto triplicate 96-microwell plates (Gibco Europe, FRG) at definite concentrations in differentiation-inducing media and incubated for 2 weeks without refeeding. The cells had been pretreated for one week by exposure to either FCS-depleted growth medium (1% FCS) or growth medium supplemented with 1 gM retinoic acid. After 14 days, the plating efficiency was determined by counting the total number of colonies and relating them to the control. Plating efficiency Pretreatment with FCS-depleted growth medium for 1 week and plating in FCS-depleted growth medium markedly affected the plating efficiency, prohibiting any colony formation at cell concentrations of up to 10 cells per microwell. (See Table III.) Effects of retinoic acid on cellular differentiation In vitro morphology Seventy-two hours after exposure to medium supplemented with 1Mm retinoic acid, the mononuclear cells of BA-HAN-IC appeared to be more elongated and spindle-shaped by phase contrast microscopy and scanning electron microscopy (Figure le and f) . In confluent cultures the cells were closely aligned side-by-side in a more orderly arrangement and piling up was significantly less evident when compared to the criss-crossed growth pattern under standard growth conditions (Figure la and b) . Transmission electron microscopy showed that about 30% of the mononuclear tumour cells (Figure 3b, c and d ) exhibited irregular bundles of thick myofilaments (12-15nm in diameter) and thin myofilaments (6-8 nm in diameter), i.e. features of rhabdomyogenic differentiation that had never been observed in their mononuclear counterparts (Figure 3a) under standard growth conditions. Substantial amounts of monoparticulate glycogen deposits ( Figure 3e ) were found in these mononuclear cells, too, and some mononuclear cells contained networks of T-system-like tubules (Figure 3f) Table I .) Figure 1 Scanning electron microscopy and phase contrast microscopy of BA-HAN-IC cells grown for one week in standard growth medium (a, b) , in medium supplemented with 1% FCS (c, d), or with I pM retinoic acid (e, f): small mononuclear cells exhibiting a criss-crossed growth pattern in standard growth medium (a) and FCS-depleted medium (c) as opposed to the more regular arrangement in medium supplemented with retinoic acid (e). Abundant myotube-like giant cells (arrows) in FCS-depleted medium (d) and in medium supplemented with retinoic acid (f) as opposed to sparsely distributed myotube-like giant cells (arrow) in standard growth medium (b). a-f: bar=20,pm. (Scarpa et al., 1975; K6nigsberg, 1977; Yaffe & Saxel, 1977; Dollenmeier & Eppenberger, 1983; Pinset & Whalen, 1983) . Therefore, we investigated the effects of FCS on a rhabdomyosarcoma cell line. Our results show that FCS-deprivation results in a marked initial retardation of proliferation ( Figure 2 ) and in a simultaneous induction of differentiation as indicated by the increase in the number of myotube-like giant cells (Table I ) and in the creatine kinase activity (Table II) . These effects may be explained by the concept of an autocrine stimulation of proliferation, proposed by Sporn and Todaro (1980) . According to this concept, cancer cells do not proliferate absolutely autonomously but in response to polypeptide growth factors, which are constitutively synthesised by the tumour cells (De Larco & Todaro, 1978; Todaro et al., 1980; Marquardt et al., 1983) . Autocrine stimulation of tumour cell proliferation, however, can be bypassed with exogeneous growth factors supplemented with calf serum. Thus, fetal calf serum has been shown to contain potent polypeptide growth factors such as PDGF, EGF and TGF-# (Alexander, 1985; Heldin et al., 1985 Heldin et al., , 1986 Florini et al., 1986; Harris et al., 1986; Sporn et al., 1987) . Consequently, FCS-deprivation in tissue culture media results in growth retardation, as could also be seen in our rhabdomyosarcoma cell line. However, the proliferation of our rhabdomyosarcoma cell line in FCS-depleted medium (Figure 2 ) markedly accelerated after 3 days in culture, when a minimum cell density had been achieved, which possibly provided a sufficient concentration of autocrine growth factors. The temporary retardation of growth observed after FCS-deprivation was accompanied by an increase in the proportion of terminally differentiated myotube-like giant cells. This observation suggests that the inverse linkage between proliferation and differentiation, which is known from normal embryonic myogenesis (Nadal-Ginard, 1978) , has been preserved in our rhabdomyosarcoma cell line. Retinoic acid is known to affect the proliferation and differentiation of both non-neoplastic and neoplastic cells (Lotan, 1979; Sporn & Roberts, 1983; Chytil, 1986; Lippmann et al., 1987a, b) , sometimes even converting tumour cells to terminally differentiated postmitotic cells (Strickland & Mahdavi, 1978; Linder et al., 1981; Sherman et al., 1985; Garvin et al., 1986; Paukovits et al., 1986; Sidell et al., 1986) . Our results show that retinoic acid inhibits proliferation and simultaneously induces terminal differentiation in our rhabdomyosarcoma cell line. ( Figure le) , suggesting a partial restoration of the contact inhibition of proliferation after exposure to retinoic acid (Lotan, 1980) . The effects of retinoic acid on proliferation were paralleled by a statistically significant increase in the frequency of terminally differentiated post-mitotic myotubelike giant cells (Table I ) and an increase in the creatine kinase activity used as a biochemical marker of differentiation (Table II) . Furthermore, about 30% of the mononuclear tumour cells exhibited morphological features of rhabdomyogenic differentiation, which had never been observed in the mononuclear tumour cells of untreated cultures ( Figure  3 ). We did not succeed, however, in converting all the cells of BA-HAN-IC into terminally differentiated post-mitotic myotube-like giant cells after exposure to retinoic acid. In our clonal cell line BA-HAN-1C, the coexistence of diverse subpopulations is not very likely to account for this partial refractoriness to retinoic acid as was suggested for other tumour models (Sherman et al., 1986; Zile et al., 1987 (Jetten, 1980; Craig et al., 1984; Amatruda et al., 1985; Thiele et al., 1985; Bentley & Groudine, 1986) . Therefore, our clonal cell line should provide a useful system for further investigations concerning the interrelations between polypeptide growth factors and retinoic acid, both of which affect the proliferation and differentiation of tumour cells. 
